121 related articles for article (PubMed ID: 8651343)
1. Massive apoptosis detected by in situ DNA nick end labeling in neuroblastoma.
Ikeda H; Hirato J; Akami M; Suzuki N; Takahashi A; Kuroiwa M; Matsuyama S
Am J Surg Pathol; 1996 Jun; 20(6):649-55. PubMed ID: 8651343
[TBL] [Abstract][Full Text] [Related]
2. Bcl-2 oncoprotein expression and apoptosis in neuroblastoma.
Ikeda H; Hirato J; Akami M; Matsuyama S; Suzuki N; Takahashi A; Kuroiwa M
J Pediatr Surg; 1995 Jun; 30(6):805-8. PubMed ID: 7666311
[TBL] [Abstract][Full Text] [Related]
3. Demonstration of apoptosis in neuroblastoma and its relationship to tumour regression.
Koizumi H; Wakisaka M; Nakada K; Takakuwa T; Fujioka T; Yamate N; Uchikoshi T
Virchows Arch; 1995; 427(2):167-73. PubMed ID: 7582247
[TBL] [Abstract][Full Text] [Related]
4. In situ detection of DNA fragmentation and expression of bcl-2 in human neuroblastoma: relation to apoptosis and spontaneous regression.
Oue T; Fukuzawa M; Kusafuka T; Kohmoto Y; Imura K; Nagahara S; Okada A
J Pediatr Surg; 1996 Feb; 31(2):251-7. PubMed ID: 8938353
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein.
Krajewski S; Chatten J; Hanada M; Reed JC
Lab Invest; 1995 Jan; 72(1):42-54. PubMed ID: 7837790
[TBL] [Abstract][Full Text] [Related]
6. The Relationship Between Apoptotic Activity and Prognostic Factors in Neuroblastomas.
Ekmekci S; Olgun N; Özer E
Turk Patoloji Derg; 2016; 32(2):99-104. PubMed ID: 27136108
[TBL] [Abstract][Full Text] [Related]
7. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification.
Castle VP; Heidelberger KP; Bromberg J; Ou X; Dole M; Nuñez G
Am J Pathol; 1993 Dec; 143(6):1543-50. PubMed ID: 8256847
[TBL] [Abstract][Full Text] [Related]
8. Cellular death in neuroblastoma: in situ correlation of apoptosis and bcl-2 expression.
Hoehner JC; Hedborg F; Wiklund HJ; Olsen L; Påhlman S
Int J Cancer; 1995 Jul; 62(1):19-24. PubMed ID: 7601561
[TBL] [Abstract][Full Text] [Related]
9. Expressions of N-myc and ras oncogene products in neuroblastoma and their correlations with prognosis.
Nakada K; Fujioka T; Kitagawa H; Takakuwa T; Yamate N
Jpn J Clin Oncol; 1993 Jun; 23(3):149-55. PubMed ID: 8350488
[TBL] [Abstract][Full Text] [Related]
10. The extent of proliferative and apoptotic activity in intraductal and invasive ductal breast carcinomas detected by Ki-67 labeling and terminal deoxynucleotidyl transferase-mediated digoxigenin-11-dUTP nick end labeling.
Shen KL; Harn HJ; Ho LI; Yu CP; Chiu SC; Lee WH
Cancer; 1998 Jun; 82(12):2373-81. PubMed ID: 9635530
[TBL] [Abstract][Full Text] [Related]
11. Role of ploidy, chromosome 1p, and Schwann cells in the maturation of neuroblastoma.
Ambros IM; Zellner A; Roald B; Amann G; Ladenstein R; Printz D; Gadner H; Ambros PF
N Engl J Med; 1996 Jun; 334(23):1505-11. PubMed ID: 8618605
[TBL] [Abstract][Full Text] [Related]
12. DNA content heterogeneity in neuroblastoma analyzed by means of image cytometry and its potential significance.
Melegh Z; Csernák E; Tóth E; Veleczki Z; Magyarosy E; Nagy K; Szentirmay Z
Virchows Arch; 2005 May; 446(5):517-24. PubMed ID: 15827757
[TBL] [Abstract][Full Text] [Related]
13. Mass screening for neuroblastoma: quo vadis? A 9-year experience from the Pediatric Oncology Study Group of the Kyushu area in Japan.
Suita S; Zaizen Y; Sera Y; Takamatsu H; Mizote H; Ohgami H; Kurosaki N; Ueda K; Tasaka H; Miyazaki S; Sugimoto T; Kawakami K; Tsuneyoshi M; Yano H; Akiyama H; Ikeda K
J Pediatr Surg; 1996 Apr; 31(4):555-8. PubMed ID: 8801312
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of N-myc oncogene amplification and S-100 protein positivity in children with neuroblastic tumors.
Hachitanda Y; Nakagawara A; Nagoshi M; Tsuneyoshi M
Acta Pathol Jpn; 1992 Sep; 42(9):639-44. PubMed ID: 1476058
[TBL] [Abstract][Full Text] [Related]
15. Neuroblastomas with discordant genotype-phenotype relationships: report of four cases with MYCN amplification and favorable histology.
Nakagawa A; Matsuoka K; Okita H; Iwafuchi H; Hori H; Kumagai M
Pediatr Dev Pathol; 2011; 14(2):87-92. PubMed ID: 21288077
[TBL] [Abstract][Full Text] [Related]
16. Detection of n-myc gene amplification in neuroblastoma by comparative, in situ,and real-time polymerase chain reaction.
Melegh Z; Bálint I; Tóth E; Csernák E; Szentirmay Z; Nagy K
Pediatr Pathol Mol Med; 2003; 22(3):213-22. PubMed ID: 12746172
[TBL] [Abstract][Full Text] [Related]
17. N-myc amplification in neuroblastomas: histopathological, DNA ploidy, and clinical variables.
Oppedal BR; Oien O; Jahnsen T; Brandtzaeg P
J Clin Pathol; 1989 Nov; 42(11):1148-52. PubMed ID: 2584426
[TBL] [Abstract][Full Text] [Related]
18. Centrosome amplification is correlated with ploidy divergence, but not with MYCN amplification, in neuroblastoma tumors.
Fukushi D; Watanabe N; Kasai F; Haruta M; Kikuchi A; Kikuta A; Kato K; Nakadate H; Tsunematsu Y; Kaneko Y
Cancer Genet Cytogenet; 2009 Jan; 188(1):32-41. PubMed ID: 19061778
[TBL] [Abstract][Full Text] [Related]
19. Expression of bcl-2 gene product in neuroblastoma.
Ramani P; Lu QL
J Pathol; 1994 Mar; 172(3):273-8. PubMed ID: 8195931
[TBL] [Abstract][Full Text] [Related]
20. N-myc genomic content and DNA ploidy in stage IVS neuroblastoma.
Bourhis J; Dominici C; McDowell H; Raschella G; Wilson G; Castello MA; Plouvier E; Lemerle J; Riou G; Bénard J
J Clin Oncol; 1991 Aug; 9(8):1371-5. PubMed ID: 2072140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
